Government panel: Hormone therapy ‘not recommended’

But actually the practice of medicine is consumed in the prevailing current in our culture. (MORE: U.S. Panel Warns Hormone-Replacement Therapy Is Too Risky ) And as is the case with any scientific finding, not everyone in the medical community is convinced that the 50,000 women would have lived had they taken estrogen therapy. But most experts agree that the results should start a serious discussion about how to communicate public-health messages so they are applied to the right populations in the correct way. What makes it a challenge is that there is not a simple set of evidence.
For the original version including any supplementary images or video, visit http://healthland.time.com/2013/07/20/hormone-replacement-therapy-could-estrogen-have-saved-50000-lives/
![]()
STORY HIGHLIGHTS Task force: Menopausal women should not use hormone therapy to prevent chronic disease Recommendation doesn’t apply to women under 50 managing menopausal symptoms Don’t undergo therapy if you don’t have symptoms of menopause, task force says (CNN) — The task force that sparked controversy with its breast cancer screening recommendations a few years ago — and PSA prostate-cancer screening pronouncements last week — is weighing in on hormone replacement therapy. But this time the U.S. Preventive Services Task Force recommendations are remarkable for their lack of controversy. The group says menopausal women should not use hormone therapy — estrogen either alone or combined with progestin — primarily to prevent chronic disease. “In the face of pretty good evidence, the balance of potential benefits and potential harms leads us not to recommend the use of these therapies,” said Dr. Kirsten Bibbins-Domingo, a task force member.
For the original version including any supplementary images or video, visit http://www.cnn.com/2012/05/29/health/conditions/hormone-replacement-therapy/index.html





